Genentech - PDFSEARCH.IO - Document Search Engine

Genentech
Results: 384

#	Item
71	Record of GMO and GM Product Dealings under Section 138 of the Gene Technology Act 2000 Dealings Involving GM products - therapeutics NB - All of these products have been approved for supply in Australia by the Therapeut Add to Reading List Source URL: www.ogtr.gov.au Language: English - Date: 2012-08-18 10:04:06 Peptide hormones Amgen Growth factors Interferon Escherichia coli Granulocyte colony-stimulating factor Genentech Insulin Saizen Biology Cytokines Eli Lilly and Company
72	Roche Half-Year Report 2008 Table of Contents Half-Year Report 2008 Key results first half 2008 Add to Reading List Source URL: www.roche.com Language: English - Date: 2014-09-09 04:00:32 Orphan drugs Genentech South San Francisco California Chugai Pharmaceutical Co. Ribbon symbolism Bevacizumab Hoffmann-La Roche Oseltamivir Breast cancer Chemistry Medicine Organic chemistry
73	Vitreo-Retinal Associates, P.C. Referral Form Diseases & Surgery of the Retina and Vitreous Jeffrey D. Zheutlin, M.D. Add to Reading List Source URL: www.vrapc.com Language: English - Date: 2015-02-23 15:29:17 Ranibizumab Macular degeneration Vascular endothelial growth factor Macular hole Genentech Regeneron Allergan Retina Epiretinal membrane Ophthalmology Vision Medicine
74	Investor science conference call from ESMO 2014 Madrid, 29 September 2014 This presentation contains certain forward-looking statements. These forward-looking statements may be identified by words such as ‘believes’ Add to Reading List Source URL: www.roche.com Language: English - Date: 2014-10-08 08:00:41 Ribbon symbolism Tyrosine kinase receptors Trastuzumab HER2/neu Breast cancer Genentech Bevacizumab Cancer immunotherapy Medicine Biology Pharmacology
75	Roche Half-Year Report[removed]Leading in biotechnology. Improving patient care. Add to Reading List Source URL: www.roche.com Language: English - Date: 2014-09-09 03:58:58 Genentech South San Francisco California UBS Swiss franc Switzerland Oseltamivir Bevacizumab Europe Investment Economy of Switzerland
76	Background Information Roche in Rheumatology: Changing the Treatment of Rheumatoid Arthritis Rheumatoid Arthritis: the treatment gap The prevalence of rheumatoid arthritis (RA) varies between 0.3% and 1% worldwide and i Add to Reading List Source URL: www.roche.com Language: English - Date: 2011-05-26 01:00:00 Immunosuppressants Connective tissue diseases Arthritis Autoimmune diseases Rheumatology Tocilizumab Rheumatoid arthritis Rituximab Genentech Health Medicine Anatomy
77	Investor science conference call from ESMO 2014 Madrid, 29 September 2014 This presentation contains certain forward-looking statements. These forward-looking statements may be identified by words such as ‘believes’ Add to Reading List Source URL: www.roche.com Language: English - Date: 2014-10-08 08:00:41 Ribbon symbolism Tyrosine kinase receptors Trastuzumab HER2/neu Breast cancer Genentech Bevacizumab Cancer immunotherapy Medicine Biology Pharmacology
78	B:8.75” T:8.5” S:8” PATIENT AUTHORIZATION AND NOTICE OF RELEASE OF Add to Reading List Source URL: www.genentech-access.com Language: English - Date: 2014-10-27 02:23:06 South San Francisco California Personally identifiable information Medical prescription Medical record Health Pharmaceutical sciences Personal life Medicine Genentech
79	On October 18, 2005, the Federal Circuit affirmed the district court’s dismissal of MedImmune’s suit seeking a declaration that U.S. Patent No. 6,331,415, which relates to human antibody production, is invalid and un Add to Reading List Source URL: www.law.umaryland.edu Language: English - Date: 2005-12-07 07:28:28 Patent law Declaratory judgment Patent prosecution United States patent law Inequitable conduct Cabilly patents Law Civil law MedImmune Inc. v. Genentech Inc.
80	RTF Document Add to Reading List Source URL: www.roche.com Language: English - Date: 2015-01-28 01:00:00 Genentech South San Francisco California Bevacizumab Targeted therapy Trastuzumab Pharmacology Medicine Drugs

UPDATE